Fortis Healthcare shares soar 24% on merger buzz

Shares of Fortis Healthcare jumped 24.5 per cent today amid reports that Manipal hospital, backed by TPG, is in advanced talks to merge the company with itself.

The stock erased its early losses and soared 24.54 per cent to Rs 157.05 on BSE during the afternoon trade.

At NSE, shares of the company zoomed 24.31 per cent to Rs 156.70.

BSE has sought clarification from Fortis Healthcare with reference to reports that Manipal hospital is in advanced talks to merge Fortis Health with itself.

Fortis Healthcare promoters Malvinder Mohan Singh and Shivinder Mohan Singh have resigned as directors from the company’s board following the Delhi High Court order upholding the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo.

The Singh brothers have jointly tendered their resignation to the Board of Fortis Healthcare, which will discuss it in the meeting on February 13, the company said in a filing to the BSE yesterday.

According to media reports, Deloitte has refused to certify Fortis Q2 results as Singh brothers have said to have taken out $78 million from the firm. BSE has sought clarification from Fortis Healthcare in this regard.

  • Related Posts

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    Six fake doctors arrested in Hyderabad

    Six fake doctors arrested in Hyderabad